QNRX

Quoin Pharmaceuticals Ltd

Stock NASDAQ – Stock Market Prices, News & Analysis

Quoin Pharmaceuticals Ltd focuses on the development and commercialization of therapies for rare skin diseases.

$ 5.65
9.16 %

Quoin Pharmaceuticals Ltd

$ 5.65
9.16 %
QNRX

Quoin Pharmaceuticals Ltd focuses on the development and commercialization of therapies for rare skin diseases.

Price history of Quoin Pharmaceuticals Ltd
Price history of Quoin Pharmaceuticals Ltd

Performance & Momentum

6 Months 30.76 %
1 Year 18.00 %
3 Years 97.13 %
5 Years 99.99 %

Strategic Analysis

Quoin Pharmaceuticals Ltd • 2026

Quoin Pharmaceuticals is positioned in the U.S. pharmaceutical sector, targeting the development of innovative treatments for rare skin diseases, a niche segment with high unmet medical need. Its business model is focused on therapeutic innovation in a specialized area, which could enable it to capture significant value in the event of clinical success.

Strengths
  • Focus on rare diseases with little direct competition
  • Significant innovation potential tied to unmet medical needs
Weaknesses
  • Very poor long-term share performance history
  • Lack of recent news flow and catalysts to support valuation
Momentum

Momentum is neutral, reflecting a period of stagnation with no clear catalyst or recent trigger. This situation calls for caution, as the valuation appears fragile in the absence of meaningful clinical or strategic progress.

Similar stocks to Quoin Pharmaceuticals Ltd

Was this page helpful?

Your feedback helps us improve our research.

Take control
of your investments

Track your portfolios, analyze your performance and receive personalized insights to invest with strategy.

  • Real-time multi-portfolio tracking
  • AI analysis of your positions
  • Counter your cognitive biases
Anantys Invest on iPhone